WILMINGTON– NeuroRx, a Wilmington clinical stage biopharma company developing the first drug regimen to treat severe bipolar depression, has retained J.P. Morgan as financial advisor. NeuroRx will begin enrolling patients […]
NeuroRx, a Wilmington biopharmaceutical company, has been granted fast-track status by the U.S. Food and Drug Administration for an experimental treatment for suicidal behavior. The company will begin enrolling patients […]
© 2023 Delaware Business Times